![Martin Dearden](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Martin Dearden
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Emergent Travel Health, Inc.
![]() Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.
13
| Subsidiary | Internet Software/Services | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Martin Dearden
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
MICROSOFT CORPORATION | Packaged Software | Private Equity Investor | |
Washington University in St. Louis | College/University | Undergraduate Degree | |
DoubleTwist, Inc.
![]() DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Doubletwist, Inc. provides genomic information and bioinformatics analysis technologies. The company is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Sales & Marketing | |
HUMANIGEN, INC. | Biotechnology | Corporate Officer/Principal | |
Wyeth Pharmaceuticals LLC
![]() Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aeras Global TB Vaccine Foundation
![]() Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Yeelion Online Network Technology (Beijing) Co., Ltd.
![]() Yeelion Online Network Technology (Beijing) Co., Ltd. Packaged SoftwareTechnology Services Yeelion Online Network Technology (Beijing) Co. Ltd. is engaged in the provision of online digital media services. Its music software, Koowo, is a media player plug-in to auto search for matching lyrics, images and music videos. The company was founded in August 2005 and is headquartered in Beijing, China. | Packaged Software | Director/Board Member | |
International AIDS Vaccine Initiative, Inc.
![]() International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
PIVOTAL THERAPEUTICS INC. | Financial Conglomerates | Director/Board Member | |
Vaxess Technologies, Inc.
![]() Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Stanford University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
The Boston Consulting Group, Inc.
![]() The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Maritime Telecommunications Network, Inc.
![]() Maritime Telecommunications Network, Inc. Specialty TelecommunicationsCommunications Maritime Telecommunications Network, Inc. provides vital and satellite communication services. It offers connectivity, digital media, system integration, and equipment. The firm serves commercial shipping, cruise and ferry, energy, enterprise, government, mobile network operators, and yacht. The company was founded in 1981 and is headquartered in Miramar, FL. | Specialty Telecommunications | Director/Board Member | |
Colby College | College/University | Undergraduate Degree | |
The University of Texas at Austin | College/University | Doctorate Degree | |
Oregon Health & Science University | College/University | Doctorate Degree | |
Wyeth Canada ULC
![]() Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Wyeth Canada ULC manufactures and distributes pharmaceutical products. The company markets products in the areas of women's health care, neuroscience, musculoskeletal therapy, transplantation and immunology, hemophilia, and vaccines. It was founded in 1907 and is headquartered in Markham, Canada. | Pharmaceuticals: Major | President | |
University of California, Santa Cruz | College/University | Undergraduate Degree | |
University of Maryland | College/University | Corporate Officer/Principal | |
Western Michigan University | College/University | Masters Business Admin | |
University of Phoenix | College/University | Masters Business Admin | |
AlphaVax, Inc.
![]() AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
University of Victoria | College/University | Undergraduate Degree | |
Liberty Dialysis LLC
![]() Liberty Dialysis LLC Medical/Nursing ServicesHealth Services Liberty Dialysis LLC develops and operates dialysis clinics. It offers chronic kidney disease outreach and home dialysis programs for patients. The firm also partners with local nephrologists and hospitals in developing, owning, and operating these centers. The company was founded by Mark Caputo and Bob Santelli in 2002 and is headquartered in Mercer Island, WA. | Medical/Nursing Services | Director/Board Member | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OrSense Ltd.
![]() OrSense Ltd. Medical DistributorsDistribution Services OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel. | Medical Distributors | Director/Board Member | |
Novartis Vaccines & Diagnostics, Inc.
![]() Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
Novartis Pharmaceuticals Canada, Inc.
![]() Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Sales & Marketing | |
The Hamlin School | Corporate Officer/Principal | ||
Covenant House, Inc. | Director/Board Member | ||
Legacy Pharmaceuticals International LLC
![]() Legacy Pharmaceuticals International LLC Financial ConglomeratesFinance Legacy Pharmaceuticals International LLC invests in pharmaceutical companies. | Financial Conglomerates | Corporate Officer/Principal | |
Karuna Foundation | Director/Board Member | ||
VALNEVA | Biotechnology | Director/Board Member | |
Novartis Vaccines & Diagnostics Services AG | Chief Tech/Sci/R&D Officer | ||
KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Coalition for Epidemic Preparedness Innovations | Corporate Officer/Principal | ||
Versatope Therapeutics, Inc.
![]() Versatope Therapeutics, Inc. BiotechnologyHealth Technology Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017. | Biotechnology | Director/Board Member | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
INVIVYD, INC. | Biotechnology | Chief Executive Officer | |
Vaccine & Infectious Disease Organization | Director/Board Member | ||
Ventana Biosciences, Inc. | Founder | ||
Sandoz Biopharmaceuticals | Corporate Officer/Principal | ||
Paxvax Corp. | Chairman Chief Executive Officer | ||
Ambulatus Robotics, Inc. | Director/Board Member | ||
Ignition Capital Partners
![]() Ignition Capital Partners Investment ManagersFinance Ignition Growth Management LLC (Ignition Capital) is a private equity subsidiary of Ignition Partners Group founded in 2007 by Jon Anderson, Rich Tong and John T. Zagula. The firm is headquartered in Bellevue, Washington. | Investment Managers | Founder |
Statistik
International
Vereinigte Staaten | 37 |
Kanada | 7 |
Frankreich | 3 |
China | 2 |
Niederlande | 2 |
Sektoral
Health Technology | 16 |
Consumer Services | 11 |
Commercial Services | 5 |
Finance | 4 |
Technology Services | 3 |
Operativ
Director/Board Member | 52 |
Corporate Officer/Principal | 21 |
Chief Executive Officer | 12 |
President | 12 |
Chief Tech/Sci/R&D Officer | 12 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Howard Rosen | 26 |
Dean Mitchell | 22 |
Rich Tong | 14 |
Jim Connolly | 12 |
Nima Farzan | 12 |
Marc J. Gurwith | 9 |
Jeremy Gowler | 9 |
Jonathan Smith | 8 |
Paul W. Shabram | 6 |
Lisa Danzig | 5 |
Thomas Yonker | 3 |
Kurt Reichen | 2 |
Kevin Smyth | 1 |
- Börse
- Insiders
- Martin Dearden
- Unternehmensverbindungen